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Bypass of Ess1 (Bye1) is a nuclear protein with a domain resem-
bling the central domain in the transcription elongation factor
TFIIS. Here we show that Bye1 binds with its TFIIS-like domain
(TLD) to RNA polymerase (Pol) II, and report crystal structures of
the Bye1 TLD bound to Pol II and three different Pol II–nucleic acid
complexes. Like TFIIS, Bye1 binds with its TLD to the Pol II jaw and
funnel. In contrast to TFIIS, however, it neither alters the confor-
mation nor the in vitro functions of Pol II. In vivo, Bye1 is recruited
to chromatin via its TLD and occupies the 5′-region of active
genes. A plant homeo domain (PHD) in Bye1 binds histone H3
tails with trimethylated lysine 4, and this interaction is enhanced
by the presence of neighboring posttranslational modifications
(PTMs) that mark active transcription and conversely is impaired
by repressive PTMs. We identify putative human homologs of
Bye1, the proteins PHD finger protein 3 and death-inducer oblit-
erator, which are both implicated in cancer. These results establish
Bye1 as the founding member of a unique family of chromatin
transcription factors that link histones with active PTMs to tran-
scribing Pol II.
gene transcription | chromatin modification
For transcription of eukaryotic protein-coding genes, RNApolymerase (Pol) II associates transiently with dozens of
transcription factors. Different Pol II–associated factors are re-
quired for transcription initiation, RNA chain elongation through
chromatin, pre-mRNA 5′-capping, splicing, 3′-RNA processing of
the nascent transcript, and transcription termination (1–3). To
understand how these factors cooperate with Pol II and achieve
their functions, structural information on Pol II in complex with
transcription factors is required. Thus far, X-ray crystallographic
structural information on such complexes is limited to two tran-
scription factors: the initiation factor TFIIB (4–7), and the elon-
gation factor TFIIS (8–11). TFIIS contains three domains, a
mobile N-terminal domain, a central domain that binds directly
to the Pol II jaw and funnel domains, and a C-terminal zinc
ribbon domain that inserts into the polymerase pore (also called
the secondary channel) and reaches the Pol II active site (9),
to stimulate cleavage of backtracked RNA during transcriptional
proofreading and escape from arrest (12).
In the yeast Saccharomyces cerevisiae, there is only a single
protein that contains a domain that is distantly homologous to
the central, Pol II–associated domain of TFIIS. This protein, by-
pass of Ess1 (Bye1), has been identified as a multicopy suppressor
of Ess1 (13), a peptidyl-prolyl cis-trans isomerase involved in
proline isomerization of the C-terminal domain (CTD) of Pol II
(14, 15). In Bye1, the central TFIIS-like domain (TLD, residues
232–365) is flanked by an N-terminal plant homeo domain (PHD)
(residues 74–134) and a C-terminal Spen paralogue and ortho-
logue C-terminal (SPOC) domain (residues 447–547; Fig. 1A).
PHD domains are mostly found in proteins involved in chromatin-
mediated gene regulation (16). Consistent with this, the Bye1 PHD
domain binds to a histone H3 tail peptide containing trimethylated
lysine 4 (H3K4me3) (17). The function of SPOC domains in yeast
is unclear, but in higher eukaryotes, SPOC domains are impli-
cated in developmental signaling (18). Bye1 localizes to the nu-
cleus (19), consistent with harboring putative nuclear localization
signals in the N-terminal protein region. Based on yeast genetics,
it was suggested that Bye1 plays an inhibitory role during tran-
scription elongation (20). It is unknown whether Bye1 binds to
Pol II directly, and what the consequences of such binding are
for polymerase structure and function.
Here we show that Bye1 binds directly to the core of Pol II
and report four crystal structures of different Pol II functional
complexes bound by Bye1. The structures reveal similarities and
differences to the Pol II–TFIIS complex. Together with func-
tional data, our results indicate that Bye1 binds to early Pol II
elongation complexes at the beginning of transcribed regions of
active genes without changing polymerase structure or function.
The polymerase interaction recruits Bye1 to chromatin, where it
directly contacts histone H3 tails marked with posttranslational
modifications (PTMs) of active transcription.
Results
Bye1 Interacts with Pol II. To test whether Pol II binds directly
to Bye1 in vitro, we incubated pure yeast Pol II with recombinant
Bye1 and subjected the sample to size-exclusion chromatography
(Materials and Methods). A stable and apparently stoichiometric
Pol II–Bye1 complex was obtained (Fig. 1B). To characterize the
Pol II–Bye1 interaction, we used surface plasmon resonance. We
immobilized Pol II on a Biacore sensor chip and determined
Bye1 association and dissociation rates. The ratio of these rates
provided a dissociation constant of KD = 3.8 ± 2.2 μM (Fig. S1).
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We also show that Bye1 binds histone tails with posttrans-
lational modifications that mark active chromatin and discuss
models for Bye1 function in a chromatin context.
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Structure of Bye1-Bound Pol II Elongation Complex.Cocrystallization
of Pol II with full-length Bye1 yielded crystals diffracting to
4.8-Å resolution (Table S1). Structure solution by molecular
replacement with free Pol II (21) revealed positive difference
density for the Bye1 TLD on the Rpb1 surface, but no density for
the two other Bye1 domains. To obtain better diffraction, the
Bye1 TLD was expressed in isolation and soaked into preformed
Pol II elongation complex crystals containing a DNA–RNA
scaffold. Diffraction data to 3.15-Å resolution were obtained
(Table S1). Phasing with the Pol II structure (21) revealed pos-
itive difference density at the same location observed with full-
length Bye1 (Fig. 1 C and D). The Bye1 TLD structure was built
with the aid of sequence markers obtained with selenomethio-
nine-labeled protein, and the complex structure was refined to a
free R-factor of 21.19% (Table S1).
Bye1 Binds the Polymerase Jaw. The Bye1 TFIIS-like domain (TLD)
fold comprises an N-terminal three-helix bundle (helices α1–α3)
followed by two short helices (α4 and α5) that link to an extended
C-terminal helix α6 (Fig. 1E). This fold resembles that of TFIIS
domain II (helices α1–α5) (9), and helix α6 corresponds to the
linker between TFIIS domains II and III (Fig. 2A). The Bye1 TLD
binds the Rpb1 jaw domain at the location where TFIIS domain II
binds the polymerase (Fig. S2A). Despite this overall similarity,
the Pol II contacts by the Bye1 TLD and TFIIS differ. The Bye1
helix α3 binds loop β30–β31 and helix α40 of the Rpb1 jaw domain
and induces ordering of loop α40–β29. Helix α6 extends from the
jaw into the Pol II funnel, contacting the Rpb1 loops α20–α21 and
β29–α41, and strand β32 of the Rpb1 funnel domain. The Bye1
loop α2–α3 contacts the N terminus of Rpb5 (Fig. 2 B–D).
Bye1 Does Not Change Pol II Conformation. TFIIS binding to Pol II
induces three major conformational changes in the polymerase
elongation complex. It repositions the jaw-lobe module, traps the
trigger loop in a locked conformation (9), and realigns the RNA
in the active site (8). Although Bye1 resembles part of TFIIS and
binds to a similar position on Pol II, it does not induce confor-
mational changes (Fig. 2E). This lack of conformational changes
was observed in structures of Pol II complexes with the Bye1
TLD, but also with full-length Bye1. These observations pre-
dicted that Bye1 does not impair nucleoside triphosphate (NTP)
binding to Pol II, which requires closure of the trigger loop. In-
deed, we were able to show closure of the trigger loop and binding
of an NTP substrate analogon in the presence of Bye1 by crys-
tallizing an additional complex of Bye1 TLD bound to the Pol II
elongation complex with α,β-Methyleneadenosine 5′-triphosphate
(AMPCPP) (Fig. 1F; Fig. S2B; Table S1). Furthermore, Bye1
TLD binding also did not prevent backtracking of RNA into the
Pol II pore, as seen in another structure of Bye1 bound to arrested
Pol II with backtracked RNA (Fig. S2C; Table S1).
Bye1 Does Not Influence Basic Pol II Functions. These observations
suggested that Bye1 had no functional influence on basal tran-
scription. Indeed nuclear extracts prepared from yeast cells lacking
the gene encoding Bye1 were active in promoter-dependent in
vitro transcription assays, and addition of purified Bye1 to WT






















































































Fig. 1. Structure of the Pol II–Bye1 elongation complex. (A) Bye1 domain organization. Bordering residue numbers are indicated. (B) Pol II and Bye1 form
a stable complex. Pol II was incubated with an excess of Bye1 and subjected to size-exclusion chromatography. The elution profile (Left) reveals a stable Pol II–
Bye1 complex (elution volume, 24.96 mL) and excess Bye1 (29.38 mL). SDS/PAGE analysis of fractions indicated with a black horizontal line confirmed the
presence of a Pol II–Bye1 complex (right lane of the Coomassie-stained SDS/PAGE gel shown on the Right). For comparison, pure Pol II and recombinant Bye1
have been included in SDS/PAGE analysis. (C) Ribbon model of the Pol II–Bye1 elongation complex crystal structure. The views correspond to the side and front
views of Pol II (46) and are related by a 90° rotation around a vertical axis. (D) Sigma-A–weighted difference electron density (blue mesh, contoured at 2.58σ)
for the Bye1 TLD (green). The Fourier coefficients used for map calculation were mFo − DFc (Fo = observed structure factor amplitude, Fc = structure factor
amplitude calculated from the Pol II structure alone, m = figure of merit, D = Sigma-A weighting factor). (E) Close-up view of the Pol II–Bye1 interaction.
Mobile loops are indicated by dashed lines. (F) Contacts of AMPCPP with the closed trigger loop in the AMPCPP-containing Pol II–Bye1 elongation complex
structure. Residues involved in hydrogen bond formation are shown as sticks; hydrogen bonds are indicated by dashed lines. A few residues of the trigger
loop that face away from the AMPCPP are mobile (dashed line).
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to TFIIS, Bye1 did not induce Pol II backtracking and RNA
cleavage on DNA–RNA scaffolds, but allowed for unperturbed
elongation activity in RNA extension assays (Fig. S4). Collectively,
these data indicate that Bye1 neither induces structural changes in
Pol II functional complexes nor influences their function in vitro.
Bye1 Associates with Chromatin via Its TLD Domain. The above results
suggested that Bye1 functions in a chromatin context. To in-
vestigate whether Bye1 associates with chromatin in vivo and
whether its Pol II–binding TLD is required for this, we bio-
chemically separated cell extracts into an insoluble fraction, con-
taining chromatin and associated proteins, and a soluble fraction,
containing free proteins in the cytoplasm and nucleoplasm. We
used strains harboring plasmids containing hemagglutinin (HA)-
tagged full-length Bye1 (WT) or variants lacking either the PHD
domain (ΔPHD) or the TLD domain (ΔTLD) (20). All variants of
Bye1 were present at the same level in unfractionated whole cell
extract (Fig. 3, lanes 1–4). WT Bye1 and its ΔPHD variant were
present in the chromatin and soluble fractions, but the ΔTLD
variant associated with chromatin only very weakly (Fig. 3,
lanes 9–12). These results demonstrate that a fraction of the
Bye1 protein present in cells associates with chromatin and that
the TLD of Bye1 is important for the association.
Bye1 Binds Active Histone Marks via Its PHD Domain. In addition to
the observations described above, it has been reported that the
Bye1 PHD domain contributes to chromatin association by bind-
ing trimethylated H3K4 peptides (17). We therefore investigated
binding of the Bye1 PHD domain to roughly 200 differentially
modified histone peptides on a microarray (22). Microarrays
were spotted at high density (∼4,000 individual features) with
histone peptides that encompass known single and combinatorial
PTMs on the core and tail domains of the four histone proteins
H3, H4, H2A, and H2B and their variants (Table S2). The Bye1
PHD domain and full-length Bye1 bound specifically to H3K4me3
peptides (Fig. 4A). The high correlation between arrays probed
with full-length Bye1 and the isolated PHD domain indicated
that the histone-binding potential of Bye1 is harbored within its
PHD domain (Fig. 4B). The interaction of Bye1 with H3K4me3
was strongly influenced by neighboring PTMs (Fig. 4C). In partic-
ular, marks of active transcription (H3K9ac, H3K14ac, H3K18ac,
and H3S10p) (23–25) enhanced Bye1 affinity to H3K4me3,
whereas marks of transcriptional repression (H3R2 and H3R8
methylation, Cit2, T3 and T6 phosphorylation, and H3K9me3)
(23, 26–29) perturbed the interaction with H3K4me3 (Fig. 4D).
Bye1 Occupies the 5′-Region of Active Genes. To test whether Bye1



















































Fig. 2. Pol II–Bye1 interaction and comparison with TFIIS. (A) Side view of the Bye1 TLD bound to Pol II (Top), TFIIS (Middle) in its Pol II-bound state (11) with
its central domain II (green), linker helix (yellow), and the C-terminal zinc ribbon domain III (orange), and superposition of the two structures (Bottom). (B)
Details of the interaction of the Bye1 TLD with the Pol II Rpb1 jaw domain (blue). The view is from the side. Residues involved in hydrogen bond formation or
salt bridges (dashed lines) are shown as sticks. (C) Side view of the Pol II Rpb1 funnel and jaw domain–Bye1 TLD interaction. (D) Details of the interaction of
the Bye1 TLD with the Pol II Rpb5 jaw domain (magenta). (E) In the Pol II–TFIIS complex structure, conformational changes in Pol II are induced by movements
of the Pol II Rpb1 loop α20–α21, which results in opening of a crevice in the polymerase funnel. Loop movements are observed for TFIIS-bound Pol II (yellow)
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Fig. 3. Bye1 associates with chromatin via its TLD domain. Immunoblot of
whole-cell extract (WCE), chromatin-bound, and soluble cell fraction to hem-
agglutinin tag (HA), histone 4 (H4), and glucose-6-phosphate-1-dehydrogenase
(G6DH). For details, see Materials and Methods.








genomic occupancy profiling with the use of ChIP (SI Materials
and Methods). Metagene analysis by averaging occupancy profiles
of genes of similar length revealed a Bye1 occupancy peak 110
nucleotides downstream of the transcription start site (TSS) (Fig.
5A). No significant signals were observed in promoter regions and
at the polyadenylation (pA) site. Bye1 was found on all active genes,
and its occupancy level correlated with those for bona fide Pol II
elongation factors such as Spt5 (Fig. S5A). Published ChIP data for
H3K4me3 shows a peak at a similar location downstream of the
TSS, although the peak is broader (Fig. S5B) (30). These results
indicated that Bye1 is recruited to the 5′-region of active genes in
vivo, and suggest that H3K4me3 contributes to Bye1 recruitment.
To interpret the ChIP data, we generated a 3D topological
model of the Bye1-bound Pol II elongation complex approaching
the +2 nucleosome of an active yeast gene (Fig. 5C). For the
modeling we assumed that Bye1 cross-links to DNA via Pol II in
H3K4me3 + K18ac
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Fig. 4. Bye1 preferentially binds histone peptides carrying PTMs of active
transcription. (A) Peptide array binding analysis reveals that Bye1 prefer-
entially associates with H3K4me3 peptides, and its PHD domain is sufficient
for this interaction. Results of two independent arrays consisting of 24 in-
dividual spots for each peptide (Table S2) are presented as relative mean
intensity measurements on a scale from 0 to 1, with 1 being the most sig-
nificant peptide interaction. (B) Scatter plot correlating relative mean in-
tensity measurements of all peptide interactions (Table S2) from arrays
probed with full-length Bye1 and the Bye1 PHD domain. H3K4me3-con-
taining peptides are shown as green dots. All other peptides on the array are
shown as black dots. The correlation coefficient was calculated by linear
regression analysis using GraphPad Prims v5. (C) Heat map depicting the
effects of combinatorial PTMs on the binding of Bye1 to H3K4me3-con-
taining peptides. Average binding intensities are represented relative to the
H3K4me3 peptide (0, white). Enhanced (>0, blue) and perturbed (<0, red)
interactions are depicted. (D) Summary of modifications enhancing (blue)
and perturbing (red) the Bye1 interaction with H3K4me3 peptides.
Bye1
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Fig. 5. Bye1 associates with active genes in front of the +2 nucleosome. (A)
Gene-averaged Bye1 ChIP occupancy profile for the median gene length class
(1,238 ± 300 nt, 339 genes). (B) Scheme showing occupancies of Bye1 and
H3K4me4 (30) derived from ChIP data and nucleosome position derived from
microarray and high-throughput DNA sequencing data (31). (C)Model of a Pol II–
nucleosome-Bye1 complex based on crystal structures and ChIP occupancy peak
positions. Distances in base pairs (bp) are indicated between the Pol II active
center and the nucleosome, as well as for the nucleosomal DNA. The model is
based on the structure of the nucleosome core particle (1aoi) (47). Modeling was
performed with Coot (48). Bye1 PHD and SPOC domains were modeled using
Modeler (49). The PHD domain model is based on structures 3kqi, 1wem, 1wew,
2lv9, and 1wep, which were identified by HHpred (50) to be most similar to Bye1
PHD. Binding of the PHD domain to H3K4me3 was modeled based on structure
2jmj. The SPOC domain model is based on structure 1ow1. (D) Bye1 genetically
interactswith Paf1 andTho2. Serial dilutions of strainsbye1Δ,paf1Δ,bye1Δpaf1Δ,
tho2Δ, bye1Δtho2Δ, and an isogenic WT control strain were placed on yeast ex-
tract peptone dextrose (YPD) plates and incubated at 30 °C for 3 d.
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ChIP experiments and set the Pol II active center to nucleotide
position +110 downstream of the TSS. We positioned the +2
nucleosome based on its experimentally defined average position
(31) (Fig. 5B). We also included models of the flexible Bye1
SPOC and PHD domains, with the latter positioned on the H3
tail emerging from the core nucleosome particle (Fig. 5C). Al-
though the trajectory of the H3 tail is unclear and although the
linkers between the Bye1 domains are flexible, the resulting model
explained the position of the ChIP peak with high H3K4me3 oc-
cupancy. The model also suggests that it is structurally possible for
Bye1 to interact simultaneously with the Pol II core and the tri-
methylated H3 tail in the 5′-region of active genes.
Bye1 Genetically Interacts with Paf1 and Tho2. To further elucidate
Bye1 function, we aimed at identifying genes that interact func-
tionally with the gene encoding Bye1. The yeast bye1Δ strain
does not show any obvious growth phenotype (20), suggesting
a nonessential function. However, it has been shown for the
transcription factor TFIIS that mutation of its functional resi-
dues, but not its deletion, confers lethality (32). This finding illus-
trates that nonessential genes can have very important functions.
Screening a yeast deletion strain collection (33, 34) for synthetic
growth defects with bye1Δ revealed two candidate genes: paf1
(RNA polymerase II associated protein 1) and tho2 (THO com-
plex subunit 2). Generating bye1Δpaf1Δ and bye1Δtho2Δ double
mutants in a different genetic background confirmed the syn-
thetic interaction between these genes (Fig. 5D). The genes paf1
and tho2 encode for subunits of two bona fide elongation factor
complexes. Paf1 belongs to the five-subunit Paf complex that
recruits the histone methyltransferase Set1 to transcribed genes
(35). Set1 in turn is responsible for H3K4 trimethylation during
transcription (36). The interaction of Bye1 PHD with H3K4me3
is therefore a plausible link between Paf1 and Bye1. Tho2 resides
in the four-subunit THO complex that is required for efficient
transcription elongation (37). These results strongly support an
involvement of Bye1 in transcription elongation through chromatin.
PHF3 and DIDO Are Human Homologs of Bye1. No homologs in
higher eukaryotes have been reported for Bye1. We performed a
bioinformatics search based on the Pfam database (38) to iden-
tify potential homologs with the same domain organization. We
found two human proteins, PHD finger protein 3 (PHF3) and
death-inducer obliterator (DIDO), which show the same domain
organization as Bye1 (Fig. 6B). Both proteins contain an N-terminal
PHD domain, a central TLD domain, and a C-terminal SPOC
domain, with linkers of varying lengths in between these domains.
Homology for both proteins could not be inferred based on se-
quence homology [E-value: 2e−04 (PHF3)/5e−04 (DIDO)]. PHF3
has been associated with glioma development because its expres-
sion is significantly reduced or lost in glioblastomas (39). DIDO
is a potential tumor suppressor showing abnormal expression
patterns in patients with myelodysplastic and myeloproliferative
diseases (40). Specific binding of the DIDO PHD domain to
H3K4me3 has been reported recently (41).
To corroborate the homology of PHF3 and DIDO with Bye1,
we analyzed the conservation of the Pol II–TLD interface. Both
yeast Pol II and Bye1 TLD surfaces forming the interface are
well conserved in human Pol II and PHF3/DIDO, respectively
(Fig. 6A; Fig. S6). In particular, a salt bridge between yeast Bye1
residue K314 and E1168 in the largest Pol II subunit Rpb1 is
conserved in the predicted human PHF3/DIDO–Pol II com-
plexes. Similarly, many hydrogen bonds observed between the
Bye1 TLD and Rpb1 (Bye1 residues N292, S311, D315, R355,
N362, and F363) are predicted to be conserved in the homolo-
gous human complexes. These results indicate that PHF3 and
DIDO contain Pol II–binding TLD domains and are human
homologs of Bye1, and our structural, biochemical, and genetic
results provide a starting point for elucidating the function of
these proteins.
Discussion
Here we show that the nuclear protein Bye1 binds to Pol II and
report crystal structures of the central TLD domain of Bye1
bound to free Pol II, a Pol II elongation complex with DNA
template and RNA transcript, an elongation complex with an
NTP analog, and an arrested elongation complex with back-
tracked RNA. These studies represent only the third high-reso-
lution structural analysis of a transcription factor complex with
the polymerase core.Whereas the previously studied factors TFIIB
(4–7, 42) and TFIIS (8–12) alter Pol II function by directly affecting
catalytic events, Bye1 does not alter basic Pol II functions in vitro.
Consistent with this, Bye1 binding to Pol II does not alter Pol II
conformation in the structures. Additional functional data in
vitro and in vivo indicate that Bye1 occupies active genes in
their 5′-region and can bind to histone H3 tails with PTMs of
active transcription using its PHD domain. A chromatin-related
function of Bye1 may explain published genetic evidence for
a negative role of Bye1 in transcription elongation (20).
What could be the function of Bye1 in chromatin transcrip-
tion? Because the TLD of Bye1 is required for chromatin asso-
ciation of Bye1, it is unlikely that Bye1 first recognizes active
chromatin marks and then recruits Pol II to active chromatin
regions. We speculate that instead Bye1 binds directly to Pol II
during early transcription elongation and tethers surrounding
histones containing active PTMs, perhaps to prevent loss of his-
tones during polymerase passage through chromatin.
Materials and Methods
Proteins were prepared either from the natural source (Pol II) or expressed
recombinantly in Escherichia coli (Bye1). For surface plasmon resonance
Sc_BYE1
Hs_PHF
      1   74  134  232    365   447   547  590
Hs_DIDO
   1  270  322                       666       783                   1057   1163 2240










Fig. 6. Conservation of Pol II–binding residues in Bye1 human homologs. (A) Amino acid sequence alignment of S. cerevisiae Bye1, H. sapiens PHF3, H. sapiens
DIDO, H. sapiens TFIIS, and S. cerevisiae TFIIS. Secondary structure elements are indicated as arrows (β-strands) or rods (α-helices). Loops are indicated with
solid lines. Residues that are part of the Pol II–Bye1 interface are marked with black triangles. Residues essential for the Pol II–TFIIS interaction (51) are marked
with black asterisks. (B) Domain organization of S. cerevisiae Bye1, H. sapiens PHF3, and H. sapiens DIDO. Numbers for bordering residues are indicated.








analysis, Pol II was immobilized on a biosensor chip (Biacore), and time-re-
solved affinity measurements of Bye1 dilution series were carried out. Pol II–
Bye1 complexes were formed with a 10× molar excess of Bye1 and cocrys-
tallized. For Pol II–Bye1 TLD complexes containing nucleic acids, Pol II and
nucleic acids were cocrystallized and Bye1 TLD was soaked into preformed
crystals. Diffraction data were collected at the Swiss Light Source, and
structures were solved by molecular replacement. For chromatin fraction-
ation, plasmids containing HA-tagged full-length Bye1, Bye1 ΔPHD (Δ1–177),
and Bye1 ΔTLD (Δ177–354) [obtained from S. D. Hanes, Division of Infectious
Disease, Wadsworth Center, New York State Department of Health, Albany,
New York (20)] were transformed into WT yeast. Chromatin fractionation was
performed using a combination of previously described methods (43, 44).
Peptide synthesis and validation, microarray fabrication, effector protein hy-
bridization and detection, and data analysis of histone peptide microarrays
were performed essentially as described previously (22). Synthetic genetic
array analysis was performed as described previously (33, 34). For details, see
SI Material and Methods.
Note Added in Proof. After our paper was submitted for publication, it was
reported that the human DNA helicase RECQL5 uses a TLD domain that is
homologous to the Bye1 TLD and binds the same Pol II region (45). This
finding is consistent with our proposal that human proteins PHF3 and DIDO
are homologs of Bye1. Bye1 may thus be the founding member of a new
family of transcription factors that link early transcribing Pol II to histones in
yeast and human cells.
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